MMP2 and Ehlers-Danlos syndrome: Of note, a recent manuscript suggests that hypermobility presentation may be dependent on folate status affecting MMP2 molecular pathways, and that EDS-related hypermobility could possibly be modulated by 5-methyltetrahydrofolate supplementation [36].